Cleaning-in-place of immunoaffinity resins monitored by in situ ATR-FTIR spectroscopy

In the next 10 years, the pharmaceutical industry anticipates that revenue from biotherapeutics will overtake those generated from small drug molecules. Despite effectively treating a range of chronic and life-threatening diseases, the high cost of biotherapeutics limits their use. For biotherapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Boulet-Audet, Maxime, Byrne, Bernadette, Kazarian, Sergei G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551555/
https://www.ncbi.nlm.nih.gov/pubmed/26159572
http://dx.doi.org/10.1007/s00216-015-8871-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551555/
https://www.ncbi.nlm.nih.gov/pubmed/26159572
http://dx.doi.org/10.1007/s00216-015-8871-3

Ejemplares similares